Department of Neurosurgery, New Jersey Pediatric Neuroscience Institute, Morristown, NJ, USA.
Department of Pediatrics, Rutgers New Jersey Medical School, Newark, NJ, USA.
Childs Nerv Syst. 2024 Aug;40(8):2609-2614. doi: 10.1007/s00381-024-06415-7. Epub 2024 Apr 22.
Marshall-Smith Syndrome (MSS) is a rare progressive developmental disorder that severely impairs a patient's intellectual development and physical health. The only known cause for MSS is a mutation in the nuclear factor 1 X (NFIX) gene. This mutation affects neuronal development and protein transcription. Historically, most patients with MSS do not survive beyond 3 years of age. Reports of ocular findings are limited. We report a case of a 9-year-old MSS patient with progressive craniosynostosis, elevated intracranial pressure, and catastrophic ocular complications. A comprehensive PubMed literature search from 2018 to August 2022 updating a previous review of older literature produced 72 articles relating to MSS, which are reviewed.
马歇尔-史密斯综合征(MSS)是一种罕见的进行性发育障碍,严重损害患者的智力发育和身体健康。MSS 的唯一已知病因是核因子 1 X(NFIX)基因突变。这种突变影响神经元发育和蛋白质转录。从历史上看,大多数 MSS 患者的寿命都不会超过 3 岁。关于眼部发现的报道有限。我们报告了一例 9 岁 MSS 患者,其表现为进行性颅缝早闭、颅内压升高和灾难性眼部并发症。从 2018 年到 2022 年 8 月,我们进行了一次全面的 PubMed 文献检索,对旧文献进行了更新,共产生了 72 篇与 MSS 相关的文章,对其进行了综述。